Ad
related to: Pfizer Third Dose- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Schedule A Vaccine
Search results
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 5 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 2 days agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 3 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Cardiff Oncology Inc (CRDF) (Q1 2024) Earnings Call Transcript Highlights: Strategic Insights ...
GuruFocus.com via Yahoo Finance· 15 hours agoThe company is leveraging Pfizer Ignite's resources to ensure effective trial execution. Q: Could you read some of the scenario planning that you...Q3/Q4 will include about ...
US opens COVID vaccine to little kids, shots begin next week
AOL· 4 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 1 day agoIt’s important to note that the vaccine maker, which employs about 5,100 people as of June 2023 and...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 2 days agoThis was compared to 67.2% efficacy for RSV and 78.8% efficacy for severe RSV in adults who had...
Earnings call: Cardiff Oncology reports on CRDF-004 trial progress By Investing.com
Investing.com· 9 hours agoCardiff Oncology, a biopharmaceutical company focused on developing new treatments for cancer, has...
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 1 day agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...
Ad
related to: Pfizer Third Dose